These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients. Baqui AA; Meiller TF; Falkler WA Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568 [TBL] [Abstract][Full Text] [Related]
6. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Rao NV; Marshall BC; Gray BH; Hoidal JR Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism. Skott P; Lucht E; Ehnlund M; Björling E Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760 [TBL] [Abstract][Full Text] [Related]
8. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241 [TBL] [Abstract][Full Text] [Related]
9. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor. Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605 [TBL] [Abstract][Full Text] [Related]
11. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. Farquhar C; VanCott TC; Mbori-Ngacha DA; Horani L; Bosire RK; Kreiss JK; Richardson BA; John-Stewart GC J Infect Dis; 2002 Oct; 186(8):1173-6. PubMed ID: 12355371 [TBL] [Abstract][Full Text] [Related]
12. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984 [TBL] [Abstract][Full Text] [Related]
13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection]. Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411 [TBL] [Abstract][Full Text] [Related]
15. Polyamine depletion down-regulates expression of the Trichomonas vaginalis cytotoxic CP65, a 65-kDa cysteine proteinase involved in cellular damage. Alvarez-Sánchez ME; Carvajal-Gamez BI; Solano-González E; Martínez-Benitez M; Garcia AF; Alderete JF; Arroyo R Int J Biochem Cell Biol; 2008; 40(11):2442-51. PubMed ID: 18586550 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Wright CD; Kennedy JA; Zitnik RJ; Kashem MA Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787 [TBL] [Abstract][Full Text] [Related]
17. The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man. Nyström M; Bergenfeldt M; Ohlsson K Scand J Clin Lab Invest; 1997 Apr; 57(2):119-25. PubMed ID: 9200270 [TBL] [Abstract][Full Text] [Related]
18. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. Fath MA; Wu X; Hileman RE; Linhardt RJ; Kashem MA; Nelson RM; Wright CD; Abraham WM J Biol Chem; 1998 May; 273(22):13563-9. PubMed ID: 9593692 [TBL] [Abstract][Full Text] [Related]